Promoting a Syndemic Approach for Cardiometabolic Disease Management During COVID-19: The CAPISCO International Expert Panel

Wael Al Mahmeed¹, Khalid Al-Rasadi², Yajnavalka Banerjee³, Antonio Ceriello⁴, Francesco Cosentino⁵, Massimo Galia⁶, Su-Yen Goh⁷, Peter Kempler⁸, Nader Lessan⁹, Nikolaos Papanas¹⁰, Ali A Rizvi^{11

12}, Raul D Santos^{13

14}, Anca P Stoian¹⁵, Peter P Toth¹⁶, Manfredi Rizzo^{12

15

17}; CArdiometabolic Panel of International experts on Syndemic COvid-19 (CAPISCO)

Affiliations

¹ Cleveland Clinic, Heart and Vascular Institute, Abu Dhabi, United Arab Emirates.
² Medical Research Center, Sultan Qaboos University, Muscat, Oman.
³ Department of Biochemistry, Mohamed Bin Rashid University, Dubai, United Arab Emirates.
⁴ IRCCS MultiMedica, Milan, Italy.
⁵ Unit of Cardiology, Karolinska Institute and Karolinska University Hospital, University of Stockholm, Stockholm, Sweden.
⁶ Department of Biomedicine, Neurosciences and Advanced Diagnostics (Bind), University of Palermo, Palermo, Italy.
⁷ Department of Endocrinology, Singapore General Hospital, Singapore, Singapore.
⁸ Department of Medicine and Oncology, Semmelweis University, Budapest, Hungary.
⁹ Imperial College London Diabetes Centre, The Research Institute, Abu Dhabi, United Arab Emirates.
¹⁰ Second Department of Internal Medicine, Diabetes Center, University Hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis, Greece.
¹¹ Department of Medicine, University of Central Florida College of Medicine, Orlando, FL, United States.
¹² Division of Endocrinology, Diabetes and Metabolism, University of South Carolina School of Medicine, Columbia, IN, United States.
¹³ Heart Institute (InCor) University of Sáo Paulo Medical School Hospital, Sáo Paulo, Brazil.
¹⁴ Hospital Israelita Albert Einstein, Sáo Paulo, Brazil.
¹⁵ Faculty of Medicine, Diabetes, Nutrition and Metabolic Diseases, Carol Davila University, Bucharest, Romania.
¹⁶ Cicarrone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
¹⁷ Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (Promise), University of Palermo, Palermo, Italy.

PMID: 34977193
PMCID: PMC8715947
DOI: 10.3389/fcvm.2021.787761

Promoting a Syndemic Approach for Cardiometabolic Disease Management During COVID-19: The CAPISCO International Expert Panel

Wael Al Mahmeed et al. Front Cardiovasc Med. 2021.

. 2021 Dec 15:8:787761.

doi: 10.3389/fcvm.2021.787761. eCollection 2021.

Authors

Affiliations

¹ Cleveland Clinic, Heart and Vascular Institute, Abu Dhabi, United Arab Emirates.
² Medical Research Center, Sultan Qaboos University, Muscat, Oman.
³ Department of Biochemistry, Mohamed Bin Rashid University, Dubai, United Arab Emirates.
⁴ IRCCS MultiMedica, Milan, Italy.
⁵ Unit of Cardiology, Karolinska Institute and Karolinska University Hospital, University of Stockholm, Stockholm, Sweden.
⁶ Department of Biomedicine, Neurosciences and Advanced Diagnostics (Bind), University of Palermo, Palermo, Italy.
⁷ Department of Endocrinology, Singapore General Hospital, Singapore, Singapore.
⁸ Department of Medicine and Oncology, Semmelweis University, Budapest, Hungary.
⁹ Imperial College London Diabetes Centre, The Research Institute, Abu Dhabi, United Arab Emirates.
¹⁰ Second Department of Internal Medicine, Diabetes Center, University Hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis, Greece.
¹¹ Department of Medicine, University of Central Florida College of Medicine, Orlando, FL, United States.
¹² Division of Endocrinology, Diabetes and Metabolism, University of South Carolina School of Medicine, Columbia, IN, United States.
¹³ Heart Institute (InCor) University of Sáo Paulo Medical School Hospital, Sáo Paulo, Brazil.
¹⁴ Hospital Israelita Albert Einstein, Sáo Paulo, Brazil.
¹⁵ Faculty of Medicine, Diabetes, Nutrition and Metabolic Diseases, Carol Davila University, Bucharest, Romania.
¹⁶ Cicarrone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
¹⁷ Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (Promise), University of Palermo, Palermo, Italy.

PMID: 34977193
PMCID: PMC8715947
DOI: 10.3389/fcvm.2021.787761

Abstract

Efforts in the fight against COVID-19 are achieving success in many parts of the world, although progress remains slow in other regions. We believe that a syndemic approach needs to be adopted to address this pandemic given the strong apparent interplay between COVID-19, its related complications, and the socio-structural environment. We have assembled an international, multidisciplinary group of researchers and clinical practitioners to promote a novel syndemic approach to COVID-19: the CArdiometabolic Panel of International experts on Syndemic COvid-19 (CAPISCO). This geographically diverse group aims to facilitate collaborative-networking and scientific exchanges between researchers and clinicians facing a multitude of challenges on different continents during the pandemic. In the present article we present our "manifesto", with the intent to provide evidence-based guidance to the global medical and scientific community for better management of patients both during and after the current pandemic.

Keywords: COVID-19; cardiovascular diseases; complications; diabetes; pandemic; syndemic.

Copyright © 2021 Al Mahmeed, Al-Rasadi, Banerjee, Ceriello, Cosentino, Galia, Goh, Kempler, Lessan, Papanas, Rizvi, Santos, Stoian, Toth, Rizzo and The CArdiometabolic Panel of International experts on Syndemic COvid-19 (CAPISCO).

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

**Figure 1**
A novel multi-disciplinary syndemic approach to cardiometabolic diseases during COVID-19.

See this image and copyright information in PMC

References

1. Ceriello A, Standl E, Catrinoiu D, Itzhak B, Lalic NM, Rahelic D, et al. Issues of cardiovascular risk management in people with diabetes in the COVID-19 era. Diabetes Care. (2020) 43:1427–32. 10.2337/dc20-0941 - DOI - PubMed
1. Khera A, Baum SJ, Gluckman TJ, Gulati M, Martin SS, Michos ED, et al. Continuity of care and outpatient management for patients with and at high risk for cardiovascular disease during the COVID-19 pandemic: A scientific statement from the American Society for Preventive Cardiology. Am J Prev Cardiol. (2020) 1:100009. 10.1016/j.ajpc.2020.100009 - DOI - PMC - PubMed
1. Schnell O, Cos X, Cosentino F, Forst T, Giorgino F, Heersprink HJL, et al. Report from the CVOT Summit 2020: new cardiovascular and renal outcomes. Cardiovasc Diabetol. (2021) 20:75. 10.1186/s12933-021-01254-1 - DOI - PMC - PubMed
1. Atallah B, El Lababidi R, Jesse W, Noor L, AlMahmeed W. Adapting to the COVID-19 pandemic at a quaternary care hospital in the Middle East Gulf region. Heart Views. (2020) 21:133–40. - PMC - PubMed
1. Ceriello A, Stoian AP, Rizzo M. COVID-19 and diabetes management: What should be considered? Diabetes Res Clin Pract. (2020) 163:108151. 10.1016/j.diabres.2020.108151 - DOI - PMC - PubMed

LinkOut - more resources

Full Text Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Promoting a Syndemic Approach for Cardiometabolic Disease Management During COVID-19: The CAPISCO International Expert Panel

Affiliations

Promoting a Syndemic Approach for Cardiometabolic Disease Management During COVID-19: The CAPISCO International Expert Panel

Authors

Affiliations

Abstract

Conflict of interest statement

Figures

References

LinkOut - more resources

Full Text Sources